Literature DB >> 27343802

Peripheral and central neuronal ATF3 precedes CD4+ T-cell infiltration in EAE.

Noémie Frezel1, Fabien Sohet2, Richard Daneman3, Allan I Basbaum4, Joao M Braz5.   

Abstract

Experimental allergic encephalomyelitis (EAE), an animal model of multiple sclerosis produced by immunization with myelin oligodendrocyte glycoprotein (MOG) and adjuvants, results from profound T-cell mediated CNS demyelination. EAE is characterized by progressive, ascending motor dysfunction and symptoms of ongoing pain and hypersensitivity, in some cases preceding or concomitant with the motor deficits. In this regard, the EAE model mimics major features of multiple sclerosis, where a central neuropathic pain state is common. Although the latter condition is presumed to arise from a CNS loss of inhibitory controls secondary to the demyelination, dysfunction of sensory neurons may also contribute. Based on our previous studies that demonstrated the utility of monitoring expression of activating transcription factor 3 (ATF3), a sensitive marker of injured sensory neurons, here we followed both ATF3 and CD4+ T cells invasion of sensory ganglia (as well as the CNS) at different stages of the EAE model. We found that ATF3 is induced in peripheral sensory ganglia and brainstem well before the appearance of motor deficits. Unexpectedly, the ATF3 induction always preceded T cell infiltration, typically in adjacent, but non-overlapping regions. Surprisingly, control administration of the pertussis toxin and/or Complete Freund's adjuvants, without MOG, induced ATF3 in sensory neurons. In contrast, T cell infiltration only occurred with MOG. Taken together, our results suggest that the clinical manifestations in the EAE result not only from central demyelination but also from neuronal stress and subsequent pathophysiology of sensory neurons.
Copyright © 2016. Published by Elsevier Inc.

Entities:  

Keywords:  ATF3; Demyelination; Dorsal root ganglion; Experimental allergic encephalomyelitis; Myelin oligodendrocyte glycoprotein; Pertussis toxin; Spinal cord

Mesh:

Substances:

Year:  2016        PMID: 27343802      PMCID: PMC5500277          DOI: 10.1016/j.expneurol.2016.06.019

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  43 in total

Review 1.  ATF3 and stress responses.

Authors:  T Hai; C D Wolfgang; D K Marsee; A E Allen; U Sivaprasad
Journal:  Gene Expr       Date:  1999

2.  Satellite glial cells in dorsal root ganglia are activated in experimental autoimmune encephalomyelitis.

Authors:  Rebekah A Warwick; Craig J Ledgerwood; Talma Brenner; Menachem Hanani
Journal:  Neurosci Lett       Date:  2014-03-29       Impact factor: 3.046

Review 3.  The ins and outs of T-lymphocyte trafficking to the CNS: anatomical sites and molecular mechanisms.

Authors:  Britta Engelhardt; Richard M Ransohoff
Journal:  Trends Immunol       Date:  2005-09       Impact factor: 16.687

Review 4.  Molecular mechanisms linking neuroinflammation and neurodegeneration in MS.

Authors:  Erik Ellwardt; Frauke Zipp
Journal:  Exp Neurol       Date:  2014-02-14       Impact factor: 5.330

Review 5.  Type 1 T helper and type 2 T helper cells: functions, regulation and role in protection and disease.

Authors:  S Romagnani
Journal:  Int J Clin Lab Res       Date:  1991

6.  Murine model of autoimmune hearing loss induced by myelin protein P0.

Authors:  H Matsuoka; K C Cheng; M S Krug; Y Yazawa; T J Yoo
Journal:  Ann Otol Rhinol Laryngol       Date:  1999-03       Impact factor: 1.547

7.  Differential ATF3 expression in dorsal root ganglion neurons reveals the profile of primary afferents engaged by diverse noxious chemical stimuli.

Authors:  João M Bráz; Allan I Basbaum
Journal:  Pain       Date:  2010-08       Impact factor: 6.961

8.  Immune-related GTPase Irgm1 exacerbates experimental auto-immune encephalomyelitis by promoting the disruption of blood-brain barrier and blood-cerebrospinal fluid barrier.

Authors:  Chaodong Wang; Caihong Wang; Haiyan Dong; Xiao-Mu Wu; Chunyu Wang; Fucan Xia; Guimei Li; Xiuzhi Jia; Shuyu He; Xiaoshu Jiang; Huashun Li; Hongwei Xu
Journal:  Mol Immunol       Date:  2012-07-13       Impact factor: 4.407

9.  Elevated expression of fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) in the dorsal root ganglia and spinal cord in experimental autoimmune encephalomyelitis: implications in multiple sclerosis-induced neuropathic pain.

Authors:  Wenjun Zhu; Crystal Acosta; Brian MacNeil; Claudia Cortes; Howard Intrater; Yuewen Gong; Mike Namaka
Journal:  Biomed Res Int       Date:  2013-09-24       Impact factor: 3.411

10.  Pertussis toxin stimulates IL-17 production in response to Bordetella pertussis infection in mice.

Authors:  Charlotte Andreasen; Daniel A Powell; Nicholas H Carbonetti
Journal:  PLoS One       Date:  2009-09-17       Impact factor: 3.240

View more
  12 in total

1.  Regulatory T Cells and Their Derived Cytokine, Interleukin-35, Reduce Pain in Experimental Autoimmune Encephalomyelitis.

Authors:  Samuel S Duffy; Brooke A Keating; Chamini J Perera; Justin G Lees; Ryan S Tonkin; Preet G S Makker; Pascal Carrive; Oleg Butovsky; Gila Moalem-Taylor
Journal:  J Neurosci       Date:  2019-01-16       Impact factor: 6.167

2.  Cutaneous tissue damage induces long-lasting nociceptive sensitization and regulation of cellular stress- and nerve injury-associated genes in sensory neurons.

Authors:  Kristofer K Rau; Caitlin E Hill; Benjamin J Harrison; Gayathri Venkat; Heidi M Koenig; Sarah B Cook; Alexander G Rabchevsky; Bradley K Taylor; Tsonwin Hai; Jeffrey C Petruska
Journal:  Exp Neurol       Date:  2016-06-03       Impact factor: 5.330

3.  Peripheral and Central Neuroinflammatory Changes and Pain Behaviors in an Animal Model of Multiple Sclerosis.

Authors:  Samuel S Duffy; Chamini J Perera; Preet G S Makker; Justin G Lees; Pascal Carrive; Gila Moalem-Taylor
Journal:  Front Immunol       Date:  2016-09-22       Impact factor: 7.561

4.  Peripheral sensory neuron injury contributes to neuropathic pain in experimental autoimmune encephalomyelitis.

Authors:  I-Ching Wang; Chen-Yen Chung; Fang Liao; Chih-Cheng Chen; Cheng-Han Lee
Journal:  Sci Rep       Date:  2017-02-09       Impact factor: 4.379

5.  Cyclic AMP Pathway Suppress Autoimmune Neuroinflammation by Inhibiting Functions of Encephalitogenic CD4 T Cells and Enhancing M2 Macrophage Polarization at the Site of Inflammation.

Authors:  Tatyana Veremeyko; Amanda W Y Yung; Marina Dukhinova; Inna S Kuznetsova; Igor Pomytkin; Alexey Lyundup; Tatyana Strekalova; Natasha S Barteneva; Eugene D Ponomarev
Journal:  Front Immunol       Date:  2018-01-25       Impact factor: 7.561

6.  Protective and therapeutic role of 2-carba-cyclic phosphatidic acid in demyelinating disease.

Authors:  Shinji Yamamoto; Kota Yamashina; Masaki Ishikawa; Mari Gotoh; Sosuke Yagishita; Kensuke Iwasa; Kei Maruyama; Kimiko Murakami-Murofushi; Keisuke Yoshikawa
Journal:  J Neuroinflammation       Date:  2017-07-21       Impact factor: 8.322

Review 7.  Mechanism of Siponimod: Anti-Inflammatory and Neuroprotective Mode of Action.

Authors:  Newshan Behrangi; Felix Fischbach; Markus Kipp
Journal:  Cells       Date:  2019-01-07       Impact factor: 6.600

8.  Cathepsin E in neutrophils contributes to the generation of neuropathic pain in experimental autoimmune encephalomyelitis.

Authors:  Yuka Harada; Jing Zhang; Kazuhisa Imari; Ryo Yamasaki; Junjun Ni; Zhou Wu; Kenji Yamamoto; Jun-Ichi Kira; Hiroshi Nakanishi; Yoshinori Hayashi
Journal:  Pain       Date:  2019-09       Impact factor: 7.926

9.  N-Acylethanolamine-Hydrolyzing Acid Amidase Inhibition, but Not Fatty Acid Amide Hydrolase Inhibition, Prevents the Development of Experimental Autoimmune Encephalomyelitis in Mice.

Authors:  Pauline Bottemanne; Owein Guillemot-Legris; Adrien Paquot; Julien Masquelier; Michael Malamas; Alexandros Makriyannis; Mireille Alhouayek; Giulio G Muccioli
Journal:  Neurotherapeutics       Date:  2021-07-07       Impact factor: 6.088

10.  Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.

Authors:  Nathalia Bernardes Teixeira; Gisele Picolo; Aline Carolina Giardini; Fawzi Boumezbeur; Géraldine Pottier; Bertrand Kuhnast; Denis Servent; Evelyne Benoit
Journal:  J Neuroinflammation       Date:  2020-09-07       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.